Centene Corporation (NYSE:CNC) is one of the best healthcare stocks under $50 to invest in. Morgan Stanley reaffirmed a Hold rating on Centene Corporation (NYSE:CNC) on February 6, setting a price target of $38.00.
The rating update came the same day Centene Corporation (NYSE:CNC) announced its 2025 results and guidance, reporting 2025 full year GAAP diluted loss per share of $13.53 and adjusted diluted Earnings Per Share of $2.08. Management reported a consolidated HBR of 94.3% in fiscal Q4 2025, which includes a Commercial HBR of 95.4%, which was 100 basis points above expectations, driven by net out-of-period items. In addition, Medicaid HBR was 93.0% in the quarter, representing 40 basis points of sequential improvement compared to Q3 and reflecting continued progress.
Centene Corporation (NYSE:CNC) further stated that it is positioned to deliver renewed adjusted diluted EPS growth and meaningful margin improvement in 2026, and expects full-year 2026 adjusted diluted EPS to be greater than $3.00. This marks significant progress toward restoring the enterprise’s embedded earnings power.
Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides programs and services to government-sponsored healthcare programs. The company’s operations are divided into the following segments: Medicaid, Medicare, Commercial, and Other.
While we acknowledge the potential of CNC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
